The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
nao geng si rong shuan hou chu xue zhuan hua yu xue ya bian yi de xiang guan xing fen xi
Author(s): 
Pages: 556-557
Year: Issue:  7
Journal: Chinese Journal of Internal Medicine

Abstract: 出血转化(hemorrhagic transformation)是急性脑梗死危害最为严重的并发症之一[1],10%~30%的脑梗死患者在接受重组组织型纤溶酶原激活物( r-tPA)溶栓治疗后会发生不同程度的出血转化.高血压是出血转化的常见危险因素[2],但血压短期变异是否会增加溶栓治疗后出血转化风险尚不明确.
Related Articles
No related articles found